Probabilities of Pituitary-Adrenal Responsiveness After Steroid Therapy
Authors: T. S. DANOWSKI
Journal: Annals of Internal Medicine (1964)

Article1 July 1964Probabilities of Pituitary-Adrenal Responsiveness After Steroid TherapyT. S. DANOWSKI, M.D., JAMES V. BONESSI, M.D., GEORGE SABEH, M.D., ROGER D. SUTTON, M.D., MARSHALL W. WEBSTER JR., MARGARET E. SARVER, M.D.T. S. DANOWSKI, M.D.Search for more papers by this author, JAMES V. BONESSI, M.D.Search for more papers by this author, GEORGE SABEH, M.D.Search for more papers by this author, ROGER D. SUTTON, M.D.Search for more papers by this author, MARSHALL W. WEBSTER JR.Search for more papers by this author, MARGARET E. SARVER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-61-1-11 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptData accumulated in this laboratory provide a basis for some generalizations concerning pituitary-adrenal responsiveness in subjects who had received adrenal steroids or adrenocorticotrophic hormone (ACTH) in small or large dosages for brief or for prolonged periods and in spontaneous Cushing's syndrome in remission after removal of an adrenal adenoma.MATERIALS AND METHODSGROUP AGroup A was made up of 117 females, 9.5 to 52 years of age, who received hydrocortisone-type steroids in replacement-displacement (that is, small) dosages in treatment of amenorrhea, hirsutism, acne, or infertility, and combinations thereof (Table 1). In most of these, the pretherapy urinary 17-ketosteroids (1)...References1. HOLTORFFKOCH AFFC: The colorimetric estimation of 17-ketosteroids and their application to urine extracts. J. Biol. Chem. 135: 377, 1940. CrossrefGoogle Scholar2. HENKEDOEJACOBSON WJRPME: A test of pituitary reserve utilizing intravenous SU 4885, with a new method for extraction of 11-desoxysteroids. J. Clin. Endocr. 20: 1527, 1960. CrossrefMedlineGoogle Scholar3. PORTERSILBER CCRH: Quantitative color reaction for cortisone and related 17, 21-dihydroxy-20-ketosteroids. J. Biol. Chem. 185: 201, 1950. CrossrefMedlineGoogle Scholar4. DANOWSKIMOSESBORECKYBALASHBONESSIGILBERTI TSCDCWRJVMV: Hydrocortisone and/or desiccated thyroid in physiologic dosage. VII. Pituitary-adrenocortical and thyroidal function. Metabolism 11: 705, 1962. MedlineGoogle Scholar5. DANOWSKIHEINEMANMOSES TSACC: Comparisons of pharmacologic dosages of ACTH and cortisone: endocrine and biochemical indices. Ibid., p. 281. Google Scholar6. BENNETT WA: Histopathological alterations of adrenal and anterior pituitary glands in patients treated with cortisone. J. Bone Joint Surg. 36A: 867, 1954. CrossrefGoogle Scholar7. KIRBYBENNETTSPRAGUE RAWARG: Anterior pituitary glands in patients treated with cortisone and corticotropin. Amer. J. Path. 33: 155, 1957. MedlineGoogle Scholar8. KITAYHOLUBJAILER JIDAJW: Hormonal regulation of pituitary adrenocorticotropin. Proc. Soc. Exp. Biol. Med. 97: 165, 1958. CrossrefMedlineGoogle Scholar9. HOLUBJAILERKITAYFRANTZ DAJWJIAG: Direct and indirect estimation of pituitary adrenocorticotropin reserves in man following adrenal steroid therapy. J. Clin. Endocr. 19: 1540, 1959. CrossrefGoogle Scholar10. KITAYHOLUBJAILER JIDAJW: Inhibition of pituitary ACTH release: an extra-adrenal action of exogenous ACTH. Endocrinology 64: 475, 1959. CrossrefMedlineGoogle Scholar11. HOLUBWALLACEJAILER DAEZJW: Pituitary adrenocorticotropin (ACTH) reserve in man following prolonged ACTH therapy. J. Clin. Endocr. 20: 1294, 1960. CrossrefGoogle Scholar12. ROBINSONMATTINGLYCOPE BHDCL: Adrenal function after prolonged corticosteroid therapy. Brit. Med. J. 1: 1579, 1962. CrossrefMedlineGoogle Scholar13. SHUSTERWILLIAMS SIA: Pituitary and adrenal functions during administration of small doses of corticosteroids. Lancet II: 674, 1961. CrossrefGoogle Scholar14. FORSHAMTHORNFRAWLEYWILSON PHGTFLW: Studies on the functional state of the adrenal cortex during and following ACTH and cortisone therapy. J. Clin. Invest. 29: 812, 1950. MedlineGoogle Scholar15. FREDELLJOHNSONKRUPPENGLEMANMCGRATH EWHPMAEPAK: Adrenocortical function during long-term cortisone therapy. Arch. Intern. Med. (Chicago) 95: 411, 1955. CrossrefGoogle Scholar16. LARZELEREBARTHOLDWILLETTFEICHTMEIRWILSONENGLEMAN RJEAFMTVLEP: Adrenocortical function in long-term treatment with corticoids. Arch. Intern. Med. (Chicago) 99: 888, 1957. CrossrefGoogle Scholar17. BIERICHKERSTENMARUEKTAD JRIS: Plasmacorticosteroids and their responsiveness to corticotrophin after long-term therapy with corticosteroids and corticotrophin. Acta Endocr. 31: 40, 1959. MedlineGoogle Scholar18. AMATRUDAHOLLINGSWORTHD'ESOPOUPTONBONDY TTDRNDCVPK: A study of the mechanism of the steroid withdrawal syndrome: evidence for integrity of the hypothalamic-pituitary-adrenal system. J. Clin. Endocr. 20: 339, 1960. CrossrefGoogle Scholar19. MARKSCHUTESALLADE LJRRL: Rapid functional suppression of the adrenal cortex due to prednisone therapy. New Eng. J. Med. 264: 10, 1961. CrossrefMedlineGoogle Scholar20. SAMPSONWINSTONEBROOKE PANEBN: Adrenal function in surgical patients after steroid therapy. Lancet II: 323, 1962. Google Scholar21. YOUNGDEFILLIPISMEYERWOLFSON IIVFLWQ: Maintenance of adrenal cortical responsiveness during prolonged corticoid therapy. Arch. Intern. Med. (Chicago) 100: 1, 1957. CrossrefGoogle Scholar22. LIDDLEESTEPKENDALLWILLIAMSTOWNES GWHLJWWCAW: Clinical application of a new test of pituitary reserve. J. Clin. Endocr. 19: 875, 1959. CrossrefMedlineGoogle Scholar23. GOLDDIRAIMONDOFORSHAM EMVCPH: Quantitation of pituitary corticotropin reserve in man by use of an adrenocortical 11-beta hydroxylase inhibitor (SU-4885). Metabolism 9: 3, 1960. MedlineGoogle Scholar24. GOLDKENTFORSHAM EMJRPH: Clinical use of a new diagnostic agent, Methopyropone (SU-4885), in pituitary and adrenocortical disorders. Ann. Intern. Med. 54: 175, 1961. LinkGoogle Scholar25. FARMERHILLPITTMANHEROD TASRJAJW: The plasma 17-hydroxycorticosteroid response to corticotropin, SU-4885 and lipopolysaccharide pyrogen. J. Clin. Endocr. 21: 433, 1961. CrossrefGoogle Scholar26. WAJCHENBERGFEDERICOMARCONDESPUPOSCHNAIDERPEREIRAGELMANMELO BLRDMAAJVGAEH: Pituitary reserve in patients on long-term steroid treatment. Arq. Brasil. Endocr. 10: 125, 1961. MedlineGoogle Scholar27. KLEINFELDERBRACHARZGEBERT HHE: The estimation of hypophyseal adrenocorticotropin (ACTH) reserve with SU 4885 (Metopiron). Klin. Wschr 39: 1153, 1961. CrossrefMedlineGoogle Scholar28. GANSULSTROM IHRA: ACTH production after an adrenal blocking agent; corticotropin production response to methopyrapone. Amer. J. Dis. Child. 104: 258, 1962. CrossrefMedlineGoogle Scholar29. PLAGERCUSHMAN JEP: Suppression of the pituitary-adrenocorticotropin (ACTH) response in man by administration of ACTH or cortisol. J. Clin. Endocr. 22: 147, 1962. CrossrefGoogle Scholar30. TREADWELLSAVAGESEVERCOPEMAN BLOEDWS: Pituitary-adrenal function during corticosteroid therapy. Lancet I: 355, 1963. CrossrefGoogle Scholar31. ARGUELLESCHEKHERDEMIANOTTONE AEMJP: 17-hydroxycorticosteroids and 17-ketosteroids in the assessment of pituitary reserve by Metopirone. Lancet I: 1275, 1962. CrossrefGoogle Scholar32. NORMAN N: The urinary excretion of 3a, 17a, 21-trihydroxy-5-pregnan-20-one (Tetrahydro S) following administration of corticotrophin and metopirone (Ciba SU 4885). Acta Endocr. 40: 375, 1962. Google Scholar33. KAPLAN NM: Tests of pituitary ACTH secretory capacity. Ann. Intern. Med. 58: 723, 1963. LinkGoogle Scholar34. NELSONMEAKIN DHJW: Pituitary and/or adrenal suppression following long-term corticosteroid therapy. Clin. Res. 8: 143, 1960. Google Scholar35. MEAKINTANTONGCOCRABBEBAYLESNELSON JWMSJTBDH: Pituitary-adrenal function following long-term steroid therapy. Amer. J. Med. 29: 459, 1960. CrossrefGoogle Scholar36. CARREONCANARYMEYERKYLE GGJJRJLH: Adrenocortical function after long-term corticoid therapy. J. Lab. Clin. Med. 56: 235, 1960. MedlineGoogle Scholar37. PFEFFERBUBLITZ KHG: The action of prednisone on the 17-hydroxy corticosteroids plasma after administration of corticotropin (ACTH) and pyrexal. Klin. Wschr. 38: 657, 1960. CrossrefMedlineGoogle Scholar38. SPRAGUEMASONMATHIESONBENNETTGASTINEAU BGHLDRWACF: Observation on the effect of cortisone on adrenal cortical structure and function in man, in Therapeutics, Vol. 2, The Blakiston Co., Philadelphia, 1951, pp. 38-48. Google Scholar39. SAVAGECOPEMANCHAPMANWELLSTREADWELL OWSLMVBL: Pituitary and adrenal hormones in rheumatoid arthritis. Lancet I: 232, 1962. CrossrefGoogle Scholar40. MARKSDONOVANDUNCANKARGER LJMJFJR: Adrenocortical response to surgical operations in patients treated with corticosteroids or corticotropin prior to surgery. J. Clin. Endocr. 19: 1458, 1959. CrossrefGoogle Scholar41. UETE T: Adrenal cortical function in chronic pulmonary tuberculosis. Brit. J. Dis. Chest. 56: 87, 1962. CrossrefMedlineGoogle Scholar42. BROWNIESPRUNT ACJG: Metopirone in the assessment of pituitary-adrenal function. Lancet I: 773, 1962. CrossrefGoogle Scholar43. KLEINTAYLORHAYSMASQUILIER RPMPU: Response of female premature newborn infants to SU 4885. J. Pediat. 61: 79, 1962. CrossrefMedlineGoogle Scholar44. FRASERPREUSSBIGFORD CGFSWD: Adrenal atrophy and irreversible shock associated with cortisone therapy. JAMA 149: 1542, 1952. CrossrefMedlineGoogle Scholar45. SALASSABENNETTKEATINGSPRAGUE RMWAFRRG: Postoperative adrenal cortical insufficiency: occurrence in patients previously treated with cortisone. JAMA 152: 1509, 1953. CrossrefMedlineGoogle Scholar46. BAYLISS RI: Surgical collapse during and after corticosteroid therapy. Brit. Med. J. 2: 935, 1958. CrossrefMedlineGoogle Scholar47. SAMPSONBROOKEJINSTONE PABNNE: Biochemical confirmation of collapse due to adrenal failure. Lancet I: 1377, 1961. CrossrefGoogle Scholar48. HARTERREDDYTHORN JGWJGW: Studies on an intermittent corticosteroid dosage regimen. New Eng. J. Med. 269: 591, 1963. CrossrefMedlineGoogle Scholar49. HERMANNWINKLER MG: Shortening of the adrenal cortical restitution phase in the guinea pig by simultaneous administration of methandrostenolone, after prolonged pretreatment with cortisone. Arzneimittelforschung 12: 82, 1961. Google Scholar50. HERMANNWINKLER MG: Effect of estradiol on the restitution phase of the adrenal cortex following long-term pretreatment with cortisone. Acta Endocr. 40: 410, 1962. MedlineGoogle Scholar51. PETERSONWYNGAARDEN REJB: The miscible pool and turnover rate of hydrocortisone in man. J. Clin. Invest. 34: 959, 1955. Google Scholar52. PETERSONWYNGAARDEN REJB: The miscible pool and turnover rate of hydrocortisone in man. J. Clin. Invest. 35: 552, 1956. CrossrefMedlineGoogle Scholar53. COPEBLACK CLEG: The behavior of 14C-cortisol and estimation of cortisol production in man. Clin. Sci. 17: 147, 1958. MedlineGoogle Scholar54. COPEBLACK CLE: The production rate of cortisol in man. Brit. Med. J. 1: 1020, 1958. CrossrefMedlineGoogle Scholar55. CRANNYKELLEY RLVC: The interpretation of steroid half-life values. J. Clin. Endocr. 19: 854, 1959. CrossrefGoogle Scholar56. BROOKSPRUNTY RVFT: Studies on the estimation of cortisol production. J. Endocr. 20: xiii, 1960. Google Scholar57. CONNFAJANSLOUISSELTZERKAINE JWSSLHHSHD: A comparison of steroidal excretion and metabolic effects induced in man by stress and by ACTH. Recent Progr. Hormone Res. 10: 471, 1954. Google Scholar58. WEXLERDOLGINTRYCZYNSKI BCAEEW: Effects of a bacterial polysaccharide (Piromen®) on the pituitary-adrenal axis: adrenal ascorbic acid, cholesterol and histologic alterations. Endocrinology 61: 300, 1957. CrossrefMedlineGoogle Scholar59. WEXLERDOLGINZAROSLINSKITRYCZYNSKI BCAEJFEW: Effects of a bacterial polysaccharide (Piromen®) on the pituitary-adrenal axis: cortisone blockade of Piromen-induced release of ACTH. Endocrinology 63: 201, 1958. CrossrefMedlineGoogle Scholar60. WEXLER BC: Effects of a bacterial polysaccharide (Piromen) on the pituitary-adrenal axis: chronic cortisone blockade of Piromen-induced release of ACTH. Metabolism 11: 626, 1962. MedlineGoogle Scholar61. ARNOLDSSONHELANDER HE: The reaction of the pituitary-adrenocortical system to stress after prolonged corticosteroid therapy. Acta Med. Scand. 173: 769, 1963. CrossrefGoogle Scholar62. MELBY JD: Assessment of adrenocorticotropic activity with bacterial pyrogen in hypopituitary states. J. Clin. Invest. 38: 1025, 1959. Google Scholar63. MELBYEGDAHLSPINK JCRHWW: Secretion and metabolism of cortisol following injection of endotoxin. J. Lab. Clin. Med. (in press); cited in J. Clin. Endocr. 21: 454, 1961. Google Scholar64. FENIMANPAGE DB: Pituitary responsiveness to stress after corticoid therapy. Lancet II: 410, 1960. Google Scholar65. HAYESKUSHLAN MASD: Influence of hormonal therapy for ulcerative colitis upon the course of surgical treatment. Gastroenterology 30: 75, 1956. CrossrefMedlineGoogle Scholar66. HAYES MA: Surgical treatment as complicated by prior adrenocortical steroid therapy. Surgery 40: 945, 1956. MedlineGoogle Scholar67. SOLEMLUND JHI: Prophylaxis with corticosteroids in surgical patients receiving cortisone or other steroid therapy. Acta Anaesth. Scand. 6: 99, 1962. CrossrefMedlineGoogle Scholar68. SAMPSONWINSTONEBROOKE PANEBN: Adrenal function in surgical patients after steroid therapy. Lancet II: 322, 1962. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Pittsburgh, PennsylvaniaFrom the Section of Endocrinology and Metabolism of the Department of Medicine, University of Pittsburgh, and the Medical Center and Shadyside Hospitals.Aided by grants from the Western Pennsylvania Heart Association, the Western Pennsylvania Arthritis and Rheumatism Foundation, the John A. Hartford Foundation, Inc., the American Medical Association, the Medical Research Foundation of Pennsylvania, Inc., and the Department of Health, Education and Welfare.Drs. Sabeh and Sarver are Clinical Fellows at the University of Pittsburgh School of Medicine. Dr. Bonessi is a Former Clinical Fellow at the University of Pittsburgh School of Medicine.Requests for reprints should be addressed to T. S. Danowski, M.D., 930-936 Health Professions Bldg., University of Pittsburgh School of Medicine, Pittsburgh 13, Pennsylvania. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByLong-term Glucocorticoid Use in Rheumatoid ArthritisAn Approach to Minimising Risk of Adrenal Insufficiency When Discontinuing Oral GlucocorticoidsDecline of Mean Initial Prednisone Dosage From 10.3 to 3.6 mg/day to Treat Rheumatoid Arthritis Between 1980 and 2004 in One Clinical Setting, With Long-Term Effectiveness of Dosages Less Than 5 mg/daySafety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot studySecondary adrenal insufficiency in an infant after intrathecal triple chemotherapyFréquence et déterminants de l’insuffisance surrénalienne biologique dépistée par le test au Synacthène® à 250μg lors du sevrage d’une corticothérapie prolongée. Étude chez 100 patientsSíndrome de Cushing exógena e retirada de glicocorticóidesCORTICOSTEROID USE IN SYSTEMIC LUPUS ERYTHEMATOSUSPerioperative management of patients treated with glucocorticoidsSTEROIDS AND THE SURGICAL PATIENTSalivary cortisol response to dental treatment of varying stressRecovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisoneOvulation Stimulation and Induction3 Glucocorticoid therapy in hyperandrogenismCorticosteroidsGlucocorticosteroid replacement therapy: A literature review and suggested replacement therapyGlucocorticoid TherapyClinical Consequences of Abrupt Drug WithdrawalStopping and restarting medications in the perioperative periodAnesthesia for Patients with Abnormal Function at the Adrenal CortexOral glucocorticoids and their complicationsAndrogen Excess in Cystic AcneResponse of the adrenal to adrenocorticotropic hormone (ACTH) in hyperandrogenic women treated chronically with low doses of prednisone**Presented in part at the Thirty-Eighth Annual Meeting of The American Fertility Society, March 20 to 24, 1982, Las Vegas, Nevada.Hypothalamic-pituitary-adrenocortical function during long-term low-dose dexamethasone therapy in hyperandrogenized womenTopical SteroidsRealistic guidelines of corticosteroid therapy in rheumatic diseasePituitary-adrenal function in women treated with low doses of prednisoneOn the various forms of corticosteroid withdrawal syndromeEndocrine Management after Pituitary SurgeryUse and abuse of systemic corticosteroid therapyTHE MODERN TOPICAL STEROIDInfluence of Acute Stimuli on Plasma Aldosterone Concentration in Anephric Man and Kidney Allograft RecipientsThe clinical significance of pituitary-adrenal suppression by exogenous corticosteroidsChronic Adrenal Cortical Insufficiency—Addison’s Disease**This work was supported in part by grant HS00240-04 from the National Center for Health Services Research and Development, Department of Health, Education, and Welfare.ReferencesPrediction of adrenal hypofunction in anaesthesiaAtopic DermatitisDie steroidinduzierte NebennierenrindenunterfunktionAdrenocorticotrophic-Hormone Deficiency in Chronic Myelogenous Leukemia after TreatmentInhibitors of adrenal cortical functionActh or Corticosteroids?: A Critical Review of Results and Possibilities in the Treatment of Severe Chronic DiseaseHazards of steroids in association with anaesthesiaAlternate-Day Prednisone TherapyTHE FUNCTION OF THE PITUITARY GLAND AND THE ADRENAL CORTEX DURING TREATMENT WITH GLUCOCORTICOIDSCorticosteroid treatment and surgery.The Hypothalamic-Pituitary AxisShock and the AdrenalOn the Pharmacologic Actions of 21-Carbon Hormonal Steroids (“Glucocorticoids”) of the Adrenal Cortex in MammalsCorticosteroid therapy in children with asthma. Hypophyseo-adrenocortical inhibition.INTERMITTENT THERAPY WITH CORTICOTROPHINIatrogenic ACTH-Cortisol Insufficiency. I. Duration of InsufficiencyHydrocortisone and/or desiccated thyroid in physiologic dosageAdrenocortical Function During Intermittent Corticosteroid TherapyDONALD A. ADAMS, M.D., ERNEST M. GOLD, M.D., HARVEY C. GONICK, M.D., F.A.C.P., MORTON H. MAXWELL, M.D., F.A.C.P.Inhibitors of adrenal cortical functionMedical Treatment of Ulcerative ColitisHereditary Addison's Disease in Relation to Diabetes MellitusClinical Assessment of the Peroral Metopirone TestWirkung von ACTH auf die Restitutionsphase der Nebennierenrinde nach langfristiger CortisongabeDie intravenöse Glucosebelastung und die Erfassung einer latenten Nebennierenrindeninsuffizienz während und nach Corticosteroidtherapie 1 July 1964Volume 61, Issue 1Page: 11-26KeywordsAcneAdrenocorticotropic hormoneEndocrinologyHeartHospital medicineInfertilityIngestionMedical educationResearch laboratoriesSteroid therapy Issue Published: 1 July 1964 PDF DownloadLoading ...